Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural proteomics: the potential of high-throughput structure determination.

Molly B Schmid1

  • 1Affinium Pharmaceuticals, 100 University Avenue, Toronto, Ontario, Canada. mschmid@afnm.com

Trends in Microbiology
|October 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interplay between chromosome stability and cell cycle control explored through gene-gene interaction and computational simulation.

Nucleic acids research·2016
Same author

Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.

Antimicrobial agents and chemotherapy·2012
Same author

Do targets limit antibiotic discovery?

Nature biotechnology·2006
Same author

Crystallizing new approaches for antimicrobial drug discovery.

Biochemical pharmacology·2006
Same author

Large-scale identification of genes required for full virulence of Staphylococcus aureus.

Journal of bacteriology·2004
Same author

Seeing is believing: the impact of structural genomics on antimicrobial drug discovery.

Nature reviews. Microbiology·2004
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
Same journal

Critical role of the inflammatory rheostat in influenza-associated pulmonary aspergillosis.

Trends in microbiology·2026
See all related articles

Genomics aids drug discovery by identifying biological targets and predicting protein structures. These insights enable structure-guided antibiotic development and target prioritization for new therapeutics.

Area of Science:

  • Genomics and Bioinformatics
  • Structural Biology
  • Drug Discovery and Development

Background:

  • The pharmaceutical industry utilizes genomics for identifying novel biological targets.
  • Genomics is increasingly important for protein structure determination and prediction.

Purpose of the Study:

  • To explore the role of genomics in advancing drug discovery.
  • To highlight the potential of protein structures in developing new antibiotics.
  • To discuss the application of structure-based criteria for target prioritization.

Main Methods:

  • Genomic data analysis for target identification.
  • Protein structure determination (experimental and computational).
  • Structure-based drug design principles.

Related Experiment Videos

Main Results:

  • Genomics facilitates the identification of new targets for drug discovery.
  • Protein structure data enables structure-guided approaches for antibiotic development.
  • Structural information aids in prioritizing targets for focused drug discovery.

Conclusions:

  • Genomics is a key driver in modern drug discovery.
  • Protein structure determination is crucial for developing novel therapeutics.
  • Structure-based strategies enhance the efficiency of drug discovery programs.